ARCHIVES

Deflecting Earmarks, NCI Advisors Lay Out Research Opportunities In Breast, Prostate

This article is from The Cancer Letter archive.

Vol. 25 No. 08 | February 26, 1999

Download PDF Visit The Full Archive

Related Articles

Stand Up To Cancer Launches Immunology “Dream Team”

December 14, 2012

In Brief: CFO Dwain Morris to Leave MD Anderson Cancer Center

May 2, 2014

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011

In Brief: BMS Chemistry Awards to Honor Fu, Wood; Groshow Joins NCI; Bowman Moves to TJU

January 15, 1999

U.S. Breast Cancer Death Rate Declines.

September 28, 2007